Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/12548512

Download in:

View as

General Info

PMID
12548512